Product Name	MF	CAS	Details

1H-Pyrazole-5-carboxamide, 4-(5-chloro-2-furanyl)-1,3-bis(2,4-difluorophenyl)-4,5-dihydro-5-methyl-N-[(4-methyl-2-morpholinyl)methyl]

C27H25ClF4N4O3

2171015-78-2

Details

BLU2864

C24H19F3N4O2

2810747-89-6

Details

Chlorantraniliprole

C18H14BrCl2N5O2

500008-45-7

Details

Cis-22a

C24H30F3N3O2

1819366-84-1

Details

Compound STK672155

C27H21ClN2O7S

339284-01-4

Details

TUG-499

C16H11Cl2NO2

1206629-08-4

Details

Vamicamide

C18H23N3O

132373-81-0

Details

Perilipin-1/5 Inhibitor 1

C23H24N2O6S

847939-23-5

Details

4-(3-Chlorophenyl)-2(3H)-thiazolone

C9H6ClNOS

1095051-68-5

Details

Chromium(III) acetate

C2H4CrO2

1066-30-4

Details

Vocacapsaicin hydrochloride

C26H42ClN3O4

1931116-92-5

Details

Anti-inflammatory agent 36

C25H27NO7

2293951-01-4

Details

mTOR inhibitor 9d

C21H23N5O3S

1144075-38-6

Details

mTOR inhibitor 9e

C22H23N5O2S

1144075-40-0

Details

GLP-1R modulator C16

C21H26ClFN2O3

875005-43-9

Details

(2S,5S)-3,6-Dioxo-2,5-piperazinediacetamide

C8H12N4O4

88206-98-8

Details

PFM39

C10H9N3OS

1310744-67-2

Details

4-Methylhistamine hydrochloride

C6H12ClN3

84103-51-5

Details

G6Pase catalytic subunit 1 inhibitor 1

C20H19N3

237402-29-8

Details

5-A-RU-PABC-Val-Cit-Fmoc

C43H53N9O13

2677841-58-4

Details

(S)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-2-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-7-carboxamide

C26H23F3N6O

1934246-20-4

Details

Anticonvulsant agent 10 HCl

1818253-48-3

Details

(S)-Vamicamide

C18H23N3O

151851-72-8

Details

PF-07038124 HCl

C18H22BNO4.ClH

2415317-57-4

Details

1-(3-chloropyridin-2-yl)piperazine 2HCl

C9H13Cl2N3

1193389-39-7

Details

Amthamine 2HCl

C6H12ClN3S

136604-58-5

Details

FLT3 kinase inhibitor 2HCl

C25H28ClN7O2

2411178-94-2

Details

(Rac)-Naxifylline

C18H24N4O3

166181-76-6

Details

1H-Indole-3-carboxylic acid, 5-[2-hydroxy-3-[[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino]propoxy]-2-methyl-1-(4-methylphenyl)-, ethyl ester

C26H34N2O7

539807-13-1

Details

YM 534

C24H36N2O4

95923-66-3

Details

1-(3,4-Dihydroxyphenyl)-2-(dimethylamino)ethanone HCl

C10H14ClNO3

16899-83-5

Details

Tamolarizine

C27H32N2O3

93035-32-6

Details

Tyrphostin AG 538

C16H11NO5

133550-18-2

Details

Simpinicline

C10H13N3

753015-44-0

Details

EM-651

C29 H31 N O4

182167-58-4

Details

Isonicotinaldehyde 2-pyridinylhydrazone

C11H10N4

2241017-37-6

Details

Hu7691 free base

C22H21F3N4O

2241232-43-7

Details

CG 428

C43H43FN10O6

2412055-93-5

Details

WDR5-47

C19H20ClFN4O3

1422389-91-0

Details

KER047

C26H30FN7O

2248154-85-8

Details

IMP-1710

C23H19N5O

2383117-96-0

Details

AChE-IN-3

C25H21N3O4

2713548-95-7

Details

Antiviral agent 38

C23H27N3O5

2247932-38-1

Details

YM 16638

C18H22N2O5S3

104073-72-5

Details

mTOR inhibitor 9b

C21H23N5O2S

1144075-34-2

Details

3,4,5-Trihydroxycinnamic acid decyl ester

C19H28O5

1770778-45-4

Details

Neuroprotective agent 1

C14H10F6N2O3

1878204-21-7

Details

1-(7-carbamimidamidoheptyl)guanidine 2HCl

2193061-39-9

Details

6'-GNTI dihydrochloride

C27H30ClN5O3

2410327-94-3

Details

Nrf2 activator-1

C30H34N4O6S

2230697-41-1

Details

Dynamin IN-2

C22H21ClN2O

1345853-49-7

Details

YT 146

90596-75-1

Details

BLU0588

C26H25N5O

2810747-78-3

Details

3-(2,6-dichlorobenzyl)-1-hexadecyl-2-methyl-1H-imidazol-3-ium iodide

Details

1-{1H-pyrrolo[2,3-d]pyrimidin-4-yl}piperazine 2HCl

C10H14ClN5

853680-06-5

Details

3-Ethyl-1-methyl-2-thioxoimidazolidin-4-one

C6H10N2OS

64895-98-3

Details

mTOR inhibitor-8

C24H19ClN4OS

2489196-70-3

Details

BTT-266

C34H28N4O4

2413939-89-4

Details

(Iso)-RJW100

C28H34O

1276664-61-9

Details

(S, R)-LSN 3318839

C26H23Cl2N3O2

2765539-92-0

Details

CYP2A6-IN-1

C12H16F3N

912291-11-3

Details

(Sar1)-Angiotensin II acetate

C51H75N13O12

102029-89-0

Details

3-phenoxy-8-azabicyclo[3.2.1]octane HCl

C13H18ClNO

1955540-15-4

Details

CAY10703 HCl

2193060-78-3

Details

Benzo[b]thiophene-7-propanoic acid, α-methoxy-4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]-, (αR)-

C24H23NO5S

849150-59-0

Details

Thalidomide-NH-CH2-COOH TFA

2377032-39-6

Details

AM-8123

C27H33N7O5S

2049973-02-4

Details

Lifitegrast

C29H24Cl2N2O7S

1025967-78-5

Details

1-[(5-Chloro-2-thienyl)sulfonyl]proline

C9H10ClNO4S2

1007999-30-5

Details

BRD4 Inhibitor 31

C11H14N2O

56369-21-2

Details

PDD00017272

C23H25N5O4S3

1945950-20-8

Details

ERα degrader-2

C29H27F3N2O2

2235396-63-9

Details

Cell-cell interaction 1

C22H30N4O2

918328-92-4

Details

mTOR inhibitor 9c

C21H22FN5O2S

1144075-36-4

Details

ALK/ROS1 inhibitor 2e HCL

Details

Y13g dihydrochloride

Details

Neramexane HCl

C11H24ClN

209185-99-9

Details

Xemilofiban

C18H22N4O4

149820-74-6

Details

L-Valyl-L-phenylalanine HCl

C14H21ClN2O3

128090-87-9

Details

mTOR inhibitor 9f

C25H23N5O2S

1144075-42-2

Details

(Hyp3)-Bradykinin acetate

Details

Antibacterial agent 170

C10H7Br2N3O3S

2163817-03-4

Details

1-(8-carbamimidamidooctyl)guanidine 2HCl

C10H26Cl2N6

25303-05-3

Details

Antitumor agent-152

C17H19N5O2S2

1209784-87-1

Details

1-(2-fluorophenyl)-3-[5-(2-methoxyphenyl)

C16H13FN4O2S

426242-86-6

Details

1H-Pyrrolo[2,1-c][1,2,4]benzothiadiazine, 2,3,3a,4-tetrahydro-, 5,5-dioxide, (3aR)-

C10H12N2O2S

175340-21-3

Details

SW2_110A

C42H60N6O7

2579696-95-8

Details

Aβ-IN-1 TFA

Details

Uk-390957

364321-71-1

Details

mTOR inhibitor 9a

C20H21N5O2S

1144075-32-0

Details

SPEN-IN-1

C27H20N4O

2863686-82-0

Details

HDAC1/5-IN-1

C26H23N3O2

380463-49-0

Details

Geranylgeranyl pyrophosphate, t-BA (1:1.5)

Details

DP-1 hydrochloride

C26H32ClN5O3

1472616-35-5

Details

6-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile

C26H31N3O2

1314134-92-3

Details

FPI-1523 sodium

C9H15N4NaO7S

1452459-52-7

Details

SH-42

C25H38O4

2143952-36-5

Details

1-(1-phenyltetrazol-5-yl)piperazine HCl

C11H15ClN6

1171471-37-6

Details

Antibacterial agent 171

C18H21NO4S

1354546-42-1

Details